Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Gauthier

Showing results (71-80 of 421) with videos related to

Pageof 43
Sort By:
Current Opinion in Neurology|August 28, 2023
Advanced brain imaging for the diagnosis of Alzheimer diseaseYi-Ting Tina Wang, Pedro Rosa-Neto, Serge Gauthier
Translational Neurodegeneration|December 6, 2012
Prevention strategies for Alzheimer's diseaseSerge Gauthier, Liyong Wu, Pedro Rosa-Neto, et al.
Expert Review of Neurotherapeutics|October 23, 2020
Impact of p-tau181 and p-tau217 levels on enrollment for randomized clinical trials and future use of anti-amyloid and anti-tau drugsSerge Gauthier, Joseph Therriault, Tharick Pascoal, et al.
Neurology|January 31, 2022
Author Response: Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, <i>APOE</i> ε4, and Cognitive ImpairmentJoseph Therriault, Tharick Pascoal, Serge Gauthier, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 27, 2014
Developments in Tau PET ImagingEduardo Rigon Zimmer, Antoine Leuzy, Serge Gauthier, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 31, 2006
Use of memantine to treat Alzheimer's diseaseSerge Gauthier, Nathan Herrmann, Florian Ferreri, et al.
Current Medical Research and Opinion|November 2, 2006
A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND StudySerge Gauthier, Angela Juby, Lidia Morelli, et al.
CNS Drugs|June 15, 2013
Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's diseaseBenoît Rive, Serge Gauthier, Sophie Costello, et al.
Dementia and Geriatric Cognitive Disorders|March 27, 2009
Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairmentSylvia Villeneuve, Sylvie Belleville, Fadi Massoud, et al.
Current Medical Research and Opinion|March 17, 2010
Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE)Serge Gauthier, Angela Juby, William Dalziel, et al.
Pageof 43

Showing results (71-80 of 421) with videos related to

Sort By:
Pageof 43
Current Opinion in Neurology|August 28, 2023
Advanced brain imaging for the diagnosis of Alzheimer diseaseYi-Ting Tina Wang, Pedro Rosa-Neto, Serge Gauthier
Translational Neurodegeneration|December 6, 2012
Prevention strategies for Alzheimer's diseaseSerge Gauthier, Liyong Wu, Pedro Rosa-Neto, et al.
Expert Review of Neurotherapeutics|October 23, 2020
Impact of p-tau181 and p-tau217 levels on enrollment for randomized clinical trials and future use of anti-amyloid and anti-tau drugsSerge Gauthier, Joseph Therriault, Tharick Pascoal, et al.
Neurology|January 31, 2022
Author Response: Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, <i>APOE</i> ε4, and Cognitive ImpairmentJoseph Therriault, Tharick Pascoal, Serge Gauthier, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 27, 2014
Developments in Tau PET ImagingEduardo Rigon Zimmer, Antoine Leuzy, Serge Gauthier, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 31, 2006
Use of memantine to treat Alzheimer's diseaseSerge Gauthier, Nathan Herrmann, Florian Ferreri, et al.
Current Medical Research and Opinion|November 2, 2006
A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND StudySerge Gauthier, Angela Juby, Lidia Morelli, et al.
CNS Drugs|June 15, 2013
Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's diseaseBenoît Rive, Serge Gauthier, Sophie Costello, et al.
Dementia and Geriatric Cognitive Disorders|March 27, 2009
Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairmentSylvia Villeneuve, Sylvie Belleville, Fadi Massoud, et al.
Current Medical Research and Opinion|March 17, 2010
Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE)Serge Gauthier, Angela Juby, William Dalziel, et al.
Pageof 43